Noah Medical announced that it received FDA clearance for its Galaxy System for robotic-navigated bronchoscopy. San Carlos, California-based Noah Medical designed Galaxy and its accessories to provide bronchoscopic visualization and access. These capabilities provide diagnostic and therapeutic procedures in patient airways. The system features advanced imaging technologies that provide real-time location updates for potentially cancerous […]
aurishealth
J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform
Ethicon, a Johnson & Johnson MedTech company, today announced the first robotic-assisted removal of kidney stones using the Monarch platform. Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022. The University of California, Irvine’s UCI Health used the Monarch platform for urology to complete the first procedure. According […]
J&J’s Auris alleges former employees brought trade secrets to new company Noah Medical
Johnson & Johnson‘s Auris Health surgical robotics business filed litigation this week alleging misappropriation of trade secrets by Noah Medical. In its complaint filed in U.S. District Court in Northern California, Auris alleges “shameless, systematic and ongoing misappropriation of trade secrets” by Noah. It named former Auris employees Enrique Romo, Diana Cardona Ujueta and Kenneth […]
FDA clears J&J’s Ethicon’s Monarch surgical robot for urology procedures
Johnson & Johnson MedTech (NYSE:JNJ) company Ethicon announced today that its Monarch robotic surgery platform received FDA 510(k) clearance. Ethicon’s Auris Health subsidiary received the FDA clearance for Monarch for endourological procedures. Company officials say it’s now the first and only multispecialty, flexible robotic solution for use in both bronchoscopy and urology. The company said […]
Encision signs supply agreement with J&J’s Auris Health
Encision today announced that it has entered a supply agreement with Johnson & Johnson (NYSE:JNJ) robotic surgery subsidiary Auris Health . Through the agreement, Auris Health will buy certain Active Electrode Monitoring technology from Encision. Boulder, Colo.–based Encision will receive an upfront payment and a milestone payment upon certain milestones. The company will also receive revenues from […]
J&J touts results of robotic bronchoscopy trial
Johnson & Johnson (NYSE:JNJ) subsidiary Auris Health is touting positive results from a study of its Monarch robotic bronchoscopy system. Monarch, a first-of-its-kind robotic technology, was cleared by the FDA in March 2018 for diagnostic and therapeutic bronchoscopies. In May, Auris touted interim results from an independent feasibility study designed to assess the platform. In that study, in 82 procedures, researchers […]
J&J’s Ethicon wins FDA breakthrough nod for microwave ablation tech
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon announced that it received FDA breakthrough device designation for its microwave ablation technology. The transbronchial microwave ablation technology, which is currently under development, utilizes robotic-assisted bronchoscopy. Johnson & Johnson’s acquisitions of NeuWave Medical and Auris Health allowed the company to bring the robotic surgical and microwave ablation technology together to […]
Appeals board agrees to examine Intuitive Surgical patent
The U.S. Patent Trial and Appeal Board has agreed to review the validity of an Intuitive Surgical (NSDQ:ISRG) patent that’s being challenged by Johnson & Johnson’s (NYSE:JNJ) Auris Health. Auris filed a petition with the PTAB in June, arguing that the patent on Intuitive’s surgical navigation guidance system covers well-known ideas, according to a report by […]
Auris Health touts FIH results for Monarch robot-assisted bronchoscopy device
Johnson & Johnson (NYSE:JNJ) subsidiary Auris Health said today that a study of its Monarch robot-assisted bronchoscopy device reached its primary effectiveness endpoint in nearly all procedures. The Benefit study assessed the platform’s ability to aid in the diagnosis of peripheral pulmonary lesions ranging from 1cm to 5cm. The Monarch platform localized targeted nodules using […]
Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali.
Newly Johnson & Johnson acquired (NYSE:JNJ) Auris Health has lost a bid to move a patent infringement it faces from competitor Intuitive Surgical (NSDQ:ISRG) from Delaware to California. In the case, filed last August, Sunnyvale, Calif.-based Intuitive Surgical claims that Auris’ Monarch robotic surgical platform infringes on eight of Intuitive’s patents. Auris Health filed a motion looking […]
J&J’s Auris touts Monarch robotic bronchoscopy feasibility study
Johnson & Johnson‘s (NYSE:JNJ) Auris Health touted this week interim results from an independent feasibility study designed to assess the company’s Monarch robotic bronchoscopy technology. The Monarch Platform was cleared by the FDA in March 2018 for diagnostic and therapeutic bronchoscopic procedures. The study was set up to test the safety and feasibility of performing […]
